TCF7L2 and coronary artery disorder: In this study, we found that the patients with the TCF7L2 rs77961654 CC genotype had reduced levels of adiponectin and Sfrp5, along with elevated HbA1c, total WBC count, and lymphocyte count, all of which are associated with an increased risk of CAD.